Th2 cytokines and asthma. Interleukin-4: Its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

Respiratory Research

Volumn 2, Issue 2, 2001, Pages 66-70

  Steinke, John W ^a   Borish, Lary ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Asthma; Genetics; Soluble recombinant human interleukin 4 receptor; T helper lymphocytes

Indexed keywords

ALTRAKINCEPT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; CELL MIGRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TARGETING; EOSINOPHIL; GENE REARRANGEMENT; GENETIC DISORDER; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; MUCUS SECRETION; NONHUMAN; PHASE 1 CLINICAL TRIAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; VASCULAR ENDOTHELIUM;

ANIMALS; ASTHMA; HUMANS; INTERLEUKIN-4; RECEPTORS, INTERLEUKIN-4; RECOMBINANT PROTEINS; TH2 CELLS;

EID: 0035719975     PISSN: 14659921     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr40     Document Type: Review

References (39)

1. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells
2. Nasal mast cells in perennial allergic rhinitis exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells
3. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo
4. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts
5. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals
6. IL-4 and TNF-α synergize to enhance eosinophil survival
7. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system
8. + T cells from T cell receptor transgenic mice
9. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures
10. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
11. Interleukin 4 (IL-4) or IL-7 prevents death of resting T cells: Stat-6 is probably not required for the effect of IL-4
12. Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of Iκ-Bα
13. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β
14. Interleukin-4 and soluble CD23 serum levels in asthmatic atopic children
15. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia
16. Allergen-induced cytokine production in atopic disease and its relationship to disease severity
17. Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics
18. + helper T cells from atopic subjects
19. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element
20. Abnormal production of T helper 2 cytokines interleukin-4 and interleukin-5 by T cells from newborns with atopic parents
21. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
22. Genetics of atopy and asthma: The rationale behind promoter-based candidate gene studies (IL-4 and IL-10)
23. IL-4/IL-13 signaling beyond JAK/STAT
24. Transcriptional repression of Stat-6-dependent IL-4 induced genes by BCL6: Specific regulation of Iε transcript expression
25. Interleukin-4 is required for the induction of lung Th2 mucosal immunity
26. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
27. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor
28. Soluble interleukin-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma
29. Cytokines in nasal fluids from school children with seasonal allergic rhinitis
30. Recombinant human interleukin-4 receptor in moderate astopic asthma: A randomized double-blind, placebo-controlled pilot study
31. Phase I/II study of recombinant interleukin-4 receptor (IL-4R) in adult patients with moderate asthma
32. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene
33. 1 in asthma
34. Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma
35. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor
36. The polymorphisms S503P and Q576R in the interleukin-4 receptor α gene are associated with atopy and influence signal transduction
37. Genetic variants of IL-13 signaling and human asthma and atopy
38. Variants of STAT-6 (signal transducer and activator of transcription 6) in atopic asthma
39. HindIII polymorphism in the BCL6 gene